Download Mobile App

Video Library

Partner Sites

MedImaging

Combining Imaging Techniques Could Enable Surgical Removal of Prostate Cancer Without Biopsy

Highly Sensitive, Foldable Detector to Make X-Rays Safer

AI Supported Detection of Cerebral Multiple Sclerosis Lesions Cuts Radiologic Reporting Times

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Automated Multi-Patient CT Injection System Reduces Patient Set-Up Time and Streamlines Workflows

Novel PCR Testing Device Represents Technological Leap in POC Infectious Disease Diagnostics

By HospiMedica International staff writers
Posted on 15 May 2023

Image: The Nuclein Anywhere PCR Test is designed to offer a simple PCR to test for infectious disease (Photo courtesy of Nuclein)

Testing for infectious diseases is vital for global health. Present testing methods, including immunochemistry and nucleic acid detection, play a crucial role in combating infectious diseases, but they also have significant drawbacks. Consequently, healthcare providers and patients often have to choose between fast and affordable results with limited sensitivity, or slower, more accurate results which often arrive too late to significantly impact outcomes. This situation often leads to lost opportunities for more effective treatment of infectious diseases. Now, a novel testing device offers a significant advancement in point-of-care infectious disease testing, potentially expanding the scope of telemedicine interactions between healthcare professionals and their patients.

Nuclein’s (Austin, TX, USA) Anywhere PCR Test is a PCR testing device designed to run a real-time PCR reaction inside an all-in-one self-test, infectious disease testing solution and delivers battery-powered, sample-to-answer results in less than an hour. This allows immediate, self-testing results to be available anywhere at the push of a button, utilizing the same standard real-time PCR technology employed by the U.S. Centers for Disease Control and Prevention (CDC), other government bodies, and commercial laboratories.

The testing device is designed to accept a saliva sample directly from the patient. The diagnostic process can be initiated by simply pressing a button, after which the device automatically prepares the sample for analysis. Test results are then automatically displayed on the LCD screen within an hour, indicating either a negative or positive result. The capacity to provide immediate results in less than an hour potentially makes the Nuclein Anywhere PCR Test an exceptionally useful tool for detecting infectious diseases, facilitating faster and more informed decision-making, ultimately leading to improved outcomes.

Related Links:
Nuclein